Quarterly results Q1 2025 results 1:02Our purposeWe are a focused biopharma company with strong momentum and big ambitions, to unite science, technology and talent to get ahead of disease together. We aim to positively impact the health of 2.5 billion people by the end of the decade, as ...
Quarterly results Q1 2025 results 1:02Our purposeWe are a focused biopharma company with strong momentum and big ambitions, to unite science, technology and talent to get ahead of disease together. We aim to positively impact the health of 2.5 billion people by the end of the decade, as ...
Quarterly results Q1 2025 results 1:02Our purposeWe are a focused biopharma company with strong momentum and big ambitions, to unite science, technology and talent to get ahead of disease together. We aim to positively impact the health of 2.5 billion people by the end of the decade, as ...
Visit our Global site for additional features Quarterly results ESG performance Codes, standards and reports Annual Report Global behind the science magazine GSK Global homepage Global investors Global mediaContinue to Company GSK This is our US website, intended for US audiences only. Other market...
Quarterly results Our latest and past quarterly results materials Analyst consensus Collated from estimates submitted by analysts Financial reports Annual Reports and Responsible Business Performance ReportsSpeeches and presentations 02 / 05 TD Cowen 45th Annual Health Care Conference Access all speeches and...
Visit our Global site for additional features Quarterly results ESG performance Codes, standards and reports Annual Report Global behind the science magazine GSK Global homepage Global investors Global mediaContinue to Company GSK This is our US website, intended for US audiences only. Other market...
Visit our Global site for additional features Quarterly results ESG performance Codes, standards and reports Annual Report Global behind the science magazine GSK Global homepage Global investors Global mediaContinue to Company GSK This is our US website, intended for US audiences only. Other market...
GSK Pakistan Annual Report 2024 Quarterly results You might also like Our products We research and develop a broad range of innovative products Pharmaceuticals and Vaccines Career opportunities at GSK Discover the work we do and the opportunities that exist, from research and development through to ma...
Frequency Quarterly More On Dividends » GLAXF Dividend Growth History More On Dividend Growth » GLAXF Ownership GLAXF Peers Risk Short Interest - Shares Short 780.69K Days to Cover 67.63 24M Beta 0.28 Altman Z Score 1.81 Technicals Title 10D SMA 50D SMA 200D SMA Simple Moving Average 17...
2024-11-13Interim Payment 0.15 GBP 2024-08-14Interim Payment 0.15 GBP 2024-05-15Interim Payment 0.15 GBP Annual results Quarterly results Quarterly revenue - Rate of surprise Net sales - Rate of surprise Annual profits - Rate of surprise